Dr. Hani El-Gabalawy is the Scientific Director of the Canadian Institutes of Health Research (CIHR) Institute for Musculoskeletal Health and Arthritis (IMHA); and Professor of Medicine and Immunology, senior clinician-scientist, Endowed Rheumatology Research Chair at the University of Manitoba, and former Section Head of Rheumatology and Arthritis Centre Director. Dr. El-Gabalawy received his pre-medical and medical studies degrees at the Faculties of Science and Medicine at the University of Calgary and completed his Internal Medicine training and Rheumatology Fellowship at McGill University. From 1997-2000, he was a visiting scientist at the National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS) in Bethesda, Maryland. In 2000, he returned to the U of Manitoba where he continued his research work in the area of pathogenesis and prognosis of early inflammatory arthritis. Dr El-Gabalawy has established a unique cohort of high risk First Nations family members of RA patients who are being followed longitudinally for the earliest evidence of RA onset for which he has received uninterrupted funding from CIHR since 2005. His current research interests centers around the pathogenesis of rheumatoid synovitis and the mechanisms involved in the initiation of synovial inflammation.